VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5635AA: VAERS reports

31 VAERS reports list lot C5635AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2019-06-28 and 2021-08-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1949%
Dermatological (non-injection-site)821%
Allergic / Anaphylactic513%
General / Systemic (non-local)38%
Musculoskeletal25%
Neurological13%
Respiratory13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Missouri3
Pennsylvania3
Colorado3
Michigan2
Massachusetts2
Maryland2
California2
Illinois2
North Carolina2
Virginia1
New York1
West Virginia1

Reports by month received

2019-062
2019-072
2019-082
2019-095
2019-102
2019-111
2020-012
2020-021
2020-031
2020-052
2020-063
2020-071
2020-091
2020-102
2021-021
2021-041
2021-071
2021-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.